Mahimox 250mg brais powder for treatment supports respiratory disorders (30 packs x 2g)

Dosage form Powder mixed drink
Specifications Box of 30 packs x 2g
Ingredient Carbocisteine
Indication Chronic respiratory infections, coughs with talks
Contraindication Gastrointestinal bleeding

Ingredient

Composition information	Content
Carbocisteine	250mg

Uses

indications

Mahimox drugs are indicated in the following cases:

Treatment of supporting respiratory disorders is characterized by excessive viscosity mucus, including chronic respiratory suffocation. secreted by the respiratory tract.

Increased glycoprotein acid and neutral ratio of mucus and the conversion of serum cells to mucus cells are known to be the first reaction to irritation and will often be followed by heat increase.

The use of carbocistein for exposed animals shows that glycoprotein is secreted normally; The indication after exposure shows that the return to normal state is accelerated.

Human studies have shown that Carbocistein reduces long -shaped cell increase. Carbocistein can be shown to be a role in managing disorders characterized by abnormal mucus.

Dynamic pharmacokinetics

Carbocistein is well absorbed and quickly through the digestive tract. After taking 750 mg of carbocistein, in a stable state (7 days) in a healthy volunteer, the peak concentration of plasma is 26 - 62.4 mg/l achieved after 1-3 hours.

Semi -cancellation time in plasma is 1.4 - 2.5 hours.

The distribution volume is about 105.2 l; Creatinine clearance is about 330 ml/ min.

Before taking Mahimox 250mg brais powder for treatment supports respiratory disorders (30 packs x 2g)

How to use

Mahimox is a water -soluble drug before drinking.

Dosage

Children from 2 - 5 years old: Take 1/2 - 1 pack/time x 2 times/day.

Children from 5 - 12 years old: Drink 1 pack of 3 times/day.

Adults (including the elderly): The first dose is usually taken 3 packs/time x 3 times/day, then if the symptoms improved the dose may be reduced to 2 packs/time x 3 times/day.

Note: The above dose is for reference only. Specific dosage depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.What to do when overdose?

Overdose: digestive disorders

How to handle: In case of overdose of the patient, the patient should be vomiting and vomiting. If not caused, gastric lavage and observation, symptomatic treatment and support.

What to do when forgetting 1 dose?

Not recorded.

Side Effects

When using Mahimox, you may experience unwanted effects (ADR).

Unknown frequency

The digestive system: vomiting, diarrhea

When experiencing side effects of the drug, it is necessary to stop using and notify the doctor or go to the nearest medical facility for timely treatment.

Warnings

Before using the drug you need to read the instructions carefully and refer to the information below.

contraindicated

Mahimox drugs contraindicated in the following cases:

Hypersensitivity to any component of the drug, patients with stomach ulcers are progressing.

Children under 2 years of age.

Caution when using

should be cautious in the elderly, in people with a history of stomach -duodenal ulcer, or those who use drugs that cause stomach bleeding. If gastrointestinal bleeding occurs, patients should stop taking the drug.

Warning related to excipients:

The drug contains lactose monohydrate: Patients with rare genetic problems are galactose intolerance, sucrase deficiency - isomaltase or Glucose - Galactose absorption disorders should not use this drug.

Aspartam -containing drugs: can be harmful to people with phenylceton.

The ability to drive and operate machinery

does not affect those who are driving, operating machines, people working on high and other jobs.

During pregnancy

Although mammals tests have shown no teratogenic effect, Mahimox is not recommended in the first three months of pregnancy.

breastfeeding period

Unknown effects.

Drug interaction

No information.

Storage

In a dry place, avoid light, temperature below 30 ° C.

Other drugs

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.